In the News… Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more!

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study links emulsifiers, a common ingrediant, to type 2 diabetes, reserachers map out the pancreas in a new way that’s already yielding new information, new guidliens about using GLP-1s and SGLT-2 medications with exisiting…

In the News.. Tandem Mobi released, surprising outcomes for type 2 surgery, exercise and diabetes studies, T1D at the Super Bowl, and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Tandem announces it’s taking orders and starting to ship the Mobi pump, Insulet gets European approval for the Abbott Libre integration with Omnipod 5, new study looks at type 2 remission and gastric…

In the News… Spray insulin tested, Dexcom T2D sensor submitted, A1C period pads… and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Vertex pauses their stem cell transplantation trials after a patient death, spray insulin is tested, learning more about Dexcom’s sensor for type 2, measuring A1C through menstrual blood and more! Find out more…

In the News… Does food-as-medicine work for T2D? Fake Ozempic warning, new Tzield research, My Cause My Cleats and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at food-as-medicine for type 2, another FDA warning about fake Ozempic, new research says gut markers may help predict who Tzield will work best for, JDRF partners with NFL…

In the News.. Arthritis drug studied for T1D, calls to poison control over Ozempic, Tandem Source released, and more!

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: an existing drug for arthritis is being studied for treatment of T1D, poison control centers report a big increase in calls about misdosing of Ozmepic and semaglutides, Tandem releases it’s Tandem Source software,…